A

Apeloa Pharmaceutical Co Ltd
SZSE:000739

Watchlist Manager
Apeloa Pharmaceutical Co Ltd
SZSE:000739
Watchlist
Price: 16.06 CNY -0.06%
Market Cap: 18.8B CNY
Have any thoughts about
Apeloa Pharmaceutical Co Ltd?
Write Note
Apeloa Pharmaceutical Co Ltd
/
Income Statement
/
Operating Income

Apeloa Pharmaceutical Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Apeloa Pharmaceutical Co Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
A
Apeloa Pharmaceutical Co Ltd
SZSE:000739
Operating Income
¥1.1B
CAGR 3-Years
5%
CAGR 5-Years
19%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Operating Income
¥2.6B
CAGR 3-Years
-2%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Operating Income
¥3.5B
CAGR 3-Years
10%
CAGR 5-Years
20%
CAGR 10-Years
24%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Operating Income
¥5.8B
CAGR 3-Years
-3%
CAGR 5-Years
3%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Operating Income
¥4B
CAGR 3-Years
2%
CAGR 5-Years
9%
CAGR 10-Years
1%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Operating Income
-¥749.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Apeloa Pharmaceutical Co Ltd
Glance View

Market Cap
18.8B CNY
Industry
Pharmaceuticals

In the bustling heart of China's pharmaceutical industry, Apeloa Pharmaceutical Co Ltd stands as a testament to strategic innovation and adaptability. Established in 1989, the company has expertly navigated the ever-evolving landscape of pharmaceuticals, becoming a significant player in both domestic and international markets. Rooted in its commitment to research and development, Apeloa has built its success on a solid foundation of producing and selling active pharmaceutical ingredients (APIs) and finished pharmaceutical products. The firm's relentless focus on quality and efficacy has not only bolstered its reputation but also expanded its footprint across various therapeutic areas, including anti-infectives, cardiovascular, and central nervous system drugs. Apeloa's ability to anticipate health trends and pivot when necessary has enabled it to remain competitive, despite the fierce challenges of the industry. Apeloa's business model is underpinned by a robust integration of its R&D efforts with a diversified manufacturing and distribution network. This integration ensures that innovations are swiftly translated into marketable solutions, generating revenue streams that fund further research endeavors. Complementing its core pharmaceutical operations, Apeloa has ventured into the realm of contract development and manufacturing services (CDMO), providing end-to-end solutions for other companies looking to scale up their production without investing in their own infrastructure. Through strategic alliances and collaborations, Apeloa capitalizes on economies of scale and taps into new markets, amplifying its profitability and enhancing shareholder value. With a keen eye on sustainability and technological advancement, Apeloa continues to chart its course in the global pharmaceutical sector, balancing growth with a commitment to improving healthcare outcomes worldwide.

Intrinsic Value
24.37 CNY
Undervaluation 34%
Intrinsic Value
Price
A
What is Intrinsic Value?

See Also

What is Apeloa Pharmaceutical Co Ltd's Operating Income?
Operating Income
1.1B CNY

Based on the financial report for Dec 31, 2023, Apeloa Pharmaceutical Co Ltd's Operating Income amounts to 1.1B CNY.

What is Apeloa Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
19%

Over the last year, the Operating Income growth was 15%. The average annual Operating Income growth rates for Apeloa Pharmaceutical Co Ltd have been 5% over the past three years , 19% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.